Unlocking the Potential of Intelligent Automation in Life Sciences

A conversation with Advisory Board member Chris Karcher, Director of Enabling Tech, Johnson & Johnson.

Find out how J&J is leveraging intelligent automation to transform their back-office operations and drive competitive advantage. Chris shares their approach to:

IA process selection
Using IA to support M&A activity
Partnering with compliance teams to ensure bots adhere to all legal and regulatory requirements
How IA will impact the pharmaceutical, biotech and medical manufacturing sectors for years to come

Please note: That all fields marked with an asterisk (*) are required.

First Name *

Last Name *

Job Title *

Company Name *

Email Address *

Telephone *

Mobile Telephone

Country *

Where did you hear about us?

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.